iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionCerity Partners LLC
Latest Disclosed Ownership69,763 shares
Latest Disclosed Value $ 11,779,792
Cerity Partners LLC reports 45.70% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 69,763 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $11,779,792 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 47,882 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 45.70% during the quarter. The current value of the position is $9,142,441 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 69,763 21,881 45.70 11,780 45.78 0.0083
2026-02-11 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 47,882 1,681 3.64 8,081 21.14 0.0118
2025-10-22 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 46,201 -311 -0.67 6,670 13.36 0.0108
2025-08-13 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 46,512 -2,555 -5.21 5,884 -6.23 0.0105
2025-04-30 2025-03-31 13F ISHARES TR ETF 464287556 49,067 -1,887 -3.70 6,276 -6.89 0.0127
2025-02-13 2024-12-31 13F ISHARES TR COM 464287556 50,954 741 1.48 6,739 -7.82 0.0146
2024-11-12 2024-09-30 13F ISHARES TR ETF 464287556 50,213 -3,061 -5.75 7,311 -0.01 0.0162
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 53,274 -6,166 -10.37 7,312 -10.35 0.0193
2024-05-14 2024-03-31 13F ISHARES TR EX TRD EQ FD 464287556 59,440 -327 -0.55 8,156 0.46 0.0215
2024-01-26 2023-12-31 13F ISHARES TR ETF 464287556 59,767 12,107 25.40 8,119 39.31 0.0267
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 47,660 -67,179 -58.50 5,828 -60.03 0.0283
2023-08-14 2023-06-30 13F ISHARES TR EX TRD EQ FD 464287556 114,839 7,378 6.87 14,580 -0.59 0.0568
2023-05-11 2023-03-31 13F ISHARES TR EX TRD EQ FD 464287556 107,461 13,298 14.12 14,667 18.64 0.0346
2023-02-15 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 94,163 79,088 524.63 12,363 601.19 0.0792
2022-11-14 2022-09-30 13F ISHARES TR ETF 464287556 15,075 -947 -5.91 1,763 -6.42 0.0212
2022-08-10 2022-06-30 13F ISHARES TR EX TRD EQ FD 464287556 16,022 -2,491 -13.46 1,884 -21.89 0.0208
2022-04-25 2022-03-31 13F ISHARES TR ETF 464287556 18,513 4,822 35.22 2,412 15.41 0.0375
2022-02-14 2021-12-31 13F ISHARES TR Stock 464287556 13,691 4,032 41.74 2,090 33.80 0.0318
2021-10-25 2021-09-30 13F iShares Nasdaq Biotechnology ETF ETF 464287556 9,659 -11 -0.11 1,562 -1.26 0.0344
2021-08-11 2021-06-30 13F ISHARES TR ETF 464287556 9,670 -11,270 -53.82 1,582 -49.83 0.0346
2021-08-11 2021-03-31 13F/A-1 ISHARES TR ETF 464287556 20,940 -39,138 -65.15 3,153 -65.36 0.0749
2021-05-12 2021-03-31 13F ISHARES TR ETF 464287556 60,090 12 9,047 0.2680
2021-02-11 2020-12-31 13F ISHARES TR ETF 464287556 60,078 36,986 160.17 9,101 191.05 0.2918
2020-11-12 2020-09-30 13F ISHARES TR COM 464287556 23,092 181 0.79 3,127 -0.13 0.1286
2020-08-17 2020-06-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 22,911 -2,020 -8.10 3,131 16.57 0.1730
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 22,911 -2,020 3,131 172,682.1380
2020-05-14 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 24,931 2,751 12.40 2,686 0.49 0.1691
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 22,180 3,708 20.07 2,673 45.43 0.1363
2019-10-30 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 18,472 0 0.00 1,838 -8.78 0.1079
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 18,472 -3,833 -17.18 2,015 -19.21 0.1270
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 22,305 -1,070 -4.58 2,494 10.65 0.1679
2019-02-06 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 23,375 199 0.86 2,254 -20.24 0.1510
2018-11-15 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 23,176 102 0.44 2,826 11.52 0.1957
2018-08-15 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 23,074 900 4.06 2,534 7.06 0.1872
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 22,174 -1,097 -4.71 2,367 -4.75 0.1810
2018-02-14 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 23,271 15,764 209.99 2,485 -0.76 0.1668
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 7,507 7,507 2,504 0.1772
2017-08-10 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -5,745 -100.00 0 -100.00
2017-05-02 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 5,745 5,745 1,685 0.1407
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.